Genovea, Dee-zayr C.

HRN: 27-62-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2025
CEFUROXIME 1.5GM (VIAL)
08/20/2025
08/21/2025
IV
1.5 G
Loading Dose
For Pelvic Laparotomy
Checking Initial Appropriateness 
08/23/2025
CEFUROXIME 1.5GM (VIAL)
08/23/2025
08/24/2025
IV
1.5g
Q8 X 2 Doses
S/p Pelvic Lap
Checking Initial Appropriateness 
08/23/2025
CEFUROXIME 500MG (TAB)
08/23/2025
08/29/2025
PO
500mg
Bid X 7 Days
S/p Pelvic Lap
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: